CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody - Phase 3 | RHHBY Pipeline | CatalystAlert